Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes

We report the synthesis and characterization of a family of benzohydrazones (Ln, n = 1-6) derived from 2-carbaldehyde-8-hydroxyquinoline and benzylhydrazides containing different substituents in the para position. Their oxidovanadium(IV) complexes were prepared and compounds with 1:1 and 1:2 metal-t...

Descripción completa

Detalles Bibliográficos
Autores: Ribeiro, Nádia|||0000-0003-2725-7781, Bulut, Ipek, Pósa, Vivien, Sergi, Baris, Sciortino, Giuseppe|||0000-0001-9657-1788, Costa Pessoa, João|||0000-0002-3978-9964, Maia, Luisa B.|||0000-0002-6901-6591, Ugone, Valeria|||0000-0002-2830-3869, Garribba, Eugenio|||0000-0002-7229-5966, Enyedy, Éva A.|||0000-0002-8058-8128, Acilan, Ceyda, Correia, Isabel|||0000-0001-7096-4284
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:288928
Acceso en línea:https://ddd.uab.cat/record/288928
https://dx.doi.org/urn:doi:10.1016/j.jinorgbio.2022.111932
Access Level:acceso abierto
Palabra clave:8-hydroxyquinoline derivatives
Anticancer
Oxidovanadium(IV) complexes
Schiff bases
Solution stability
Speciation
SDG 3 - Good Health and Well-being
id ES_7a0d0290ffa0a39a8bfbd8375c3f4c49
oai_identifier_str oai:ddd.uab.cat:288928
network_acronym_str ES
network_name_str España
repository_id_str
spelling Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexesRibeiro, Nádia|||0000-0003-2725-7781Bulut, IpekPósa, VivienSergi, BarisSciortino, Giuseppe|||0000-0001-9657-1788Costa Pessoa, João|||0000-0002-3978-9964Maia, Luisa B.|||0000-0002-6901-6591Ugone, Valeria|||0000-0002-2830-3869Garribba, Eugenio|||0000-0002-7229-5966Enyedy, Éva A.|||0000-0002-8058-8128Acilan, CeydaCorreia, Isabel|||0000-0001-7096-42848-hydroxyquinoline derivativesAnticancerOxidovanadium(IV) complexesSchiff basesSolution stabilitySpeciationSDG 3 - Good Health and Well-beingWe report the synthesis and characterization of a family of benzohydrazones (Ln, n = 1-6) derived from 2-carbaldehyde-8-hydroxyquinoline and benzylhydrazides containing different substituents in the para position. Their oxidovanadium(IV) complexes were prepared and compounds with 1:1 and 1:2 metal-to-ligand stoichiometry were obtained. All compounds were characterized by elemental analyses and mass spectrometry as well as FTIR, UV-visible absorption, NMR (ligand precursors) and EPR (complexes) spectroscopies, and by DFT computational methods. Proton dissociation constants, lipophilicity and solubility in aqueous media were determined for all ligand precursors. Complex formation with V(IV)O was evaluated by spectrophotometry for L4 (Me-substituted) and L6 (OH-substituted) and formation constants for mono [VO(HL)]+, [VO(L)] and bis [VO(HL)2], [VO(HL)(L)]-, [VO(L)2]2- complexes were determined. EPR spectroscopy indicates the formation of [VO(HL)]+ and [VO(HL)2], with this latter being the major species at the physiological pH. Noteworthy, the EPR data suggest a different behaviour for L4 and L6, which confirm the results obtained in the solid state. The antiproliferative activity of all compounds was evaluated in malignant melanoma (A-375) and lung (A-549) cancer cells. All complexes show much higher activity on A-375 (IC50 < 6.3 μM) than in A-549 cells (IC50 > 20 μM). Complex 3 (F-substituted) shows the lowest IC50 on both cell lines and lower than cisplatin (in A-375). Studies identified this compound as the one showing the highest increase in Annexin-V staining, caspase activity and induction of double stranded breaks, corroborating the cytotoxicity results. The mechanism of action of the complexes involves reactive oxygen species (ROS) induced DNA damage, and cell death by apoptosis. 22022-01-0120222022-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/288928https://dx.doi.org/urn:doi:10.1016/j.jinorgbio.2022.111932reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengMinisterio de Ciencia e Innovación https://doi.org/10.13039/501100004837 FJC2019-039135-Iopen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:2889282026-06-06T12:50:31Z
dc.title.none.fl_str_mv Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes
title Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes
spellingShingle Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes
Ribeiro, Nádia|||0000-0003-2725-7781
8-hydroxyquinoline derivatives
Anticancer
Oxidovanadium(IV) complexes
Schiff bases
Solution stability
Speciation
SDG 3 - Good Health and Well-being
title_short Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes
title_full Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes
title_fullStr Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes
title_full_unstemmed Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes
title_sort Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes
dc.creator.none.fl_str_mv Ribeiro, Nádia|||0000-0003-2725-7781
Bulut, Ipek
Pósa, Vivien
Sergi, Baris
Sciortino, Giuseppe|||0000-0001-9657-1788
Costa Pessoa, João|||0000-0002-3978-9964
Maia, Luisa B.|||0000-0002-6901-6591
Ugone, Valeria|||0000-0002-2830-3869
Garribba, Eugenio|||0000-0002-7229-5966
Enyedy, Éva A.|||0000-0002-8058-8128
Acilan, Ceyda
Correia, Isabel|||0000-0001-7096-4284
author Ribeiro, Nádia|||0000-0003-2725-7781
author_facet Ribeiro, Nádia|||0000-0003-2725-7781
Bulut, Ipek
Pósa, Vivien
Sergi, Baris
Sciortino, Giuseppe|||0000-0001-9657-1788
Costa Pessoa, João|||0000-0002-3978-9964
Maia, Luisa B.|||0000-0002-6901-6591
Ugone, Valeria|||0000-0002-2830-3869
Garribba, Eugenio|||0000-0002-7229-5966
Enyedy, Éva A.|||0000-0002-8058-8128
Acilan, Ceyda
Correia, Isabel|||0000-0001-7096-4284
author_role author
author2 Bulut, Ipek
Pósa, Vivien
Sergi, Baris
Sciortino, Giuseppe|||0000-0001-9657-1788
Costa Pessoa, João|||0000-0002-3978-9964
Maia, Luisa B.|||0000-0002-6901-6591
Ugone, Valeria|||0000-0002-2830-3869
Garribba, Eugenio|||0000-0002-7229-5966
Enyedy, Éva A.|||0000-0002-8058-8128
Acilan, Ceyda
Correia, Isabel|||0000-0001-7096-4284
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv 8-hydroxyquinoline derivatives
Anticancer
Oxidovanadium(IV) complexes
Schiff bases
Solution stability
Speciation
SDG 3 - Good Health and Well-being
topic 8-hydroxyquinoline derivatives
Anticancer
Oxidovanadium(IV) complexes
Schiff bases
Solution stability
Speciation
SDG 3 - Good Health and Well-being
description We report the synthesis and characterization of a family of benzohydrazones (Ln, n = 1-6) derived from 2-carbaldehyde-8-hydroxyquinoline and benzylhydrazides containing different substituents in the para position. Their oxidovanadium(IV) complexes were prepared and compounds with 1:1 and 1:2 metal-to-ligand stoichiometry were obtained. All compounds were characterized by elemental analyses and mass spectrometry as well as FTIR, UV-visible absorption, NMR (ligand precursors) and EPR (complexes) spectroscopies, and by DFT computational methods. Proton dissociation constants, lipophilicity and solubility in aqueous media were determined for all ligand precursors. Complex formation with V(IV)O was evaluated by spectrophotometry for L4 (Me-substituted) and L6 (OH-substituted) and formation constants for mono [VO(HL)]+, [VO(L)] and bis [VO(HL)2], [VO(HL)(L)]-, [VO(L)2]2- complexes were determined. EPR spectroscopy indicates the formation of [VO(HL)]+ and [VO(HL)2], with this latter being the major species at the physiological pH. Noteworthy, the EPR data suggest a different behaviour for L4 and L6, which confirm the results obtained in the solid state. The antiproliferative activity of all compounds was evaluated in malignant melanoma (A-375) and lung (A-549) cancer cells. All complexes show much higher activity on A-375 (IC50 < 6.3 μM) than in A-549 cells (IC50 > 20 μM). Complex 3 (F-substituted) shows the lowest IC50 on both cell lines and lower than cisplatin (in A-375). Studies identified this compound as the one showing the highest increase in Annexin-V staining, caspase activity and induction of double stranded breaks, corroborating the cytotoxicity results. The mechanism of action of the complexes involves reactive oxygen species (ROS) induced DNA damage, and cell death by apoptosis.
publishDate 2022
dc.date.none.fl_str_mv 2
2022-01-01
2022
2022-01-01
dc.type.none.fl_str_mv Article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://ddd.uab.cat/record/288928
https://dx.doi.org/urn:doi:10.1016/j.jinorgbio.2022.111932
url https://ddd.uab.cat/record/288928
https://dx.doi.org/urn:doi:10.1016/j.jinorgbio.2022.111932
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.relation.none.fl_str_mv Ministerio de Ciencia e Innovación https://doi.org/10.13039/501100004837 FJC2019-039135-I
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Dipòsit Digital de Documents de la UAB
instname:Universitat Autònoma de Barcelona
instname_str Universitat Autònoma de Barcelona
reponame_str Dipòsit Digital de Documents de la UAB
collection Dipòsit Digital de Documents de la UAB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869411408763944960
score 15,300724